Lessons learned from phase 3 trials of immunotherapy for glioblastoma: Time for longitudinal sampling? (vol 26, pg 211, 2023)

Chen, ET; Ling, AL; Reardon, DA; Chiocca, EA

NEURO-ONCOLOGY, 2023; ():